定量影像组学特征与深度学习用于胃癌PD-L1表达水平的无创评估:一项数字活检研究
该研究纳入217例胃癌胃切除术患者,从术前增强CT提取1205个影像组学特征构建影像标签并联合临床因素建立多层感知机模型,用于无创预测PD-L1表达水平。模型在训练组AUC为0.806(95%CI: 0.736-0.875),外部验证组AUC为0.784(95%CI: 0.668-0.901),提示深度学习联合定量影像特征可作为胃癌PD-L1表达无创评估的潜在方法。
要点
- 术前增强CT影像组学联合临床因素可无创预测胃癌PD-L1高表达,外部验证AUC为0.784。
- 影像标签由15个定量特征经回归随机森林模型构建,与PD-L1表达水平显著相关。
- 该数字活检系统有望为胃癌免疫治疗决策提供提示性信息,但尚未替代病理检测。
核心结论
- 深度学习联合定量影像组学特征的无创数字活检系统可较好区分胃癌PD-L1高表达与低表达,训练组AUC为0.806(95%CI: 0.736-0.875),外部验证组AUC为0.784(95%CI: 0.668-0.901)。
研究设计与样本
- 回顾性连续纳入217例接受胃切除术的胃癌患者,中心1的157例为训练组,中心2的60例为外部验证组。
- 从术前增强CT图像提取1205个定量影像组学特征,经回归随机森林模型构建影像标签,再与临床因素整合入多层感知机模型。
- 采用ROC曲线和校准曲线在训练组与外部验证组评估数字活检系统性能。
诊断标准与关键数值
- 共筛选15个特征构建影像标签,该标签在训练组(p<0.0001)和外部验证组(p<0.01)均与PD-L1表达水平显著相关。
- 影像标签联合临床因素的混合深度学习模型区分PD-L1高表达:训练组AUC=0.806(95%CI: 0.736-0.875),外部验证组AUC=0.784(95%CI: 0.668-0.901)。
临床应用与阅片要点
- 阅片时可关注术前增强CT中与PD-L1表达相关的定量影像组学特征,但需注意该模型尚处于研究阶段,不能替代病理PD-L1检测。
- 报告时可提示影像组学联合临床因素模型对PD-L1高表达有辅助预测价值,为免疫治疗决策提供参考信息。
局限性
- 原文未明确报告研究局限性;作为回顾性多中心研究,外部验证样本量较小(60例),模型泛化能力仍需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Programmed Death-Ligand 1 (PD-L1) is an important biomarker for patient selection of immunotherapy in gastric cancer (GC). This study aimed to construct and validate a non-invasive virtual biopsy system based on radiological features and clinical factors to predict the PD-L1 expression level in GC.
MATERIALS AND METHODS: 217 patients who received gastrectomy for GC were consecutively enrolled in this study, with 157 patients from center 1 as the training cohort and 60 patients from center 2 as the external validation cohort. 1205 quantitative radiomics features were extracted from preprocessed pre-operative contrast-enhanced CT images of enrolled patients. A radiological signature was computed using a regression random forest model and was integrated with clinical factors in a multilayer perceptron. The performance of the digital biopsy system was evaluated by the receiver operating characteristic (ROC) curve and calibration curve in both the training and validation cohort.
RESULTS: 15 features were selected for the construction of radiological signature, which was significantly associated with expression levels of PD-L1 in both the training cohort (p<0.0001) and the external validation cohort (p<0.01). The hybrid deep learning model integrating the radiological signature and clinical factor could accurately distinguish GCs with high PD-L1 expression levels in both the training cohort (AUC = 0.806, 95%CI: 0.736-0.875) and the validation cohort (AUC = 0.784, 95%CI: 0.668-0.901).
CONCLUSIONS: Our results indicate that the combination of deep learning and quantitative radiological features are potential approaches for the non-invasive evaluation of PD-L1 expression levels in GC. The digital biopsy system could provide valuable suggestive information for clinical decision-making of immunotherapy in GC.
引用
- Xie, Jiang, Zhou, et al. Quantitative Radiological Features and Deep Learning for the Non-Invasive Evaluation of Programmed Death Ligand 1 Expression Levels in Gastric Cancer Patients: A Digital Biopsy Study. Acad Radiol. 2022. PMID: 36369191. doi:10.1016/j.acra.2022.10.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。